Here's What a $2,000 Investment in Broadcom Today Could Be Worth by 2030

Broadcom expects AI revenue to rise from $58 billion this year to $230 billion in fiscal 2028, and CEO Hock Tan said the company is on target to exceed $30 in fiscal 2028 EPS. The article estimates that $2,000 invested at the cited $352 share price could reach about $4,000 by 2030 at $30 EPS and a low-20s multiple, or about $5,000 if EPS reaches $40. Those outcomes depend on continued AI demand and favorable valuation; supply-chain disruption, geopolitical shocks, or an industry downturn remain risks.

Analysis

AVGO: Forecast risk matters more than the headline multiple. The valuation case uses earnings two fiscal years forward, then assumes both delivery and a return to a low-20s multiple; this is not evidence the shares are cheap today. The key vulnerability is a narrow bridge from hyperscaler capex to Broadcom revenue: customer-specific design wins must ship on schedule, and advanced packaging, memory, networking and foundry capacity must all scale together. A bottleneck anywhere can defer revenue while leaving fixed development costs and a high-growth valuation intact.

Custom accelerators are a credible substitution threat to NVIDIA in selected inference and workload-specific deployments, but not a simple one-for-one displacement: GPUs retain flexibility, and growing AI workloads could expand both markets. The second-order risk is that hyperscalers use custom silicon to lower costs and bargaining power, pressuring vendor economics even as unit volumes rise. Alphabet, Amazon and Meta benefit from more compute options, but their capex plans remain the demand-side dependency rather than independent confirmation of Broadcom’s forecast.

Near term, this promotional valuation framework is unlikely to be a catalyst by itself. Over 1–3 months, track Broadcom’s reported AI revenue, customer/program commentary and supply constraints alongside hyperscaler capex guidance. Over 6–18 months, shipment conversion and repeat design wins determine whether the earnings path is durable. The contrarian concern: the market may be underestimating execution and customer concentration risk; alternatively, a broad AI-spending pause could make even strong design wins insufficient. Treat management targets as claims to verify, not booked revenue.

Key Decisions for Investors

• Do not buy solely on the cited forward multiple or the article’s 2030 scenario. First verify the definition and composition of the AI revenue outlook, customer concentration, and whether announced programs have moved into volume shipments.
• For an existing AVGO position, retain exposure only within a defined portfolio risk budget; consider trimming into sharp rallies if estimates rise without corresponding shipment or cash-flow confirmation. Reassess on the next earnings report and hyperscaler capex updates.
• Watchlist, not an immediate pair trade: a relative-value long AVGO / short NVDA could benefit if custom-chip deployments gain share, but only after evidence of sustained AVGO shipment growth and no material deterioration in NVIDIA demand. Falsify the thesis if Broadcom reduces its AI outlook, reports material delivery constraints, or hyperscaler capex guidance rolls over.
• Key downside indicators are delayed accelerator programs, weaker-than-expected AI revenue conversion, rising supply-chain lead times, or a capex pause at Alphabet, Amazon or Meta. These would challenge both the earnings estimates and the assumed valuation rerating.